Filing Details
- Accession Number:
- 0001140361-24-009784
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-27 16:58:15
- Reporting Period:
- 2024-02-23
- Accepted Time:
- 2024-02-27 16:58:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9326 | Balchem Corp | BCPC | Chemicals & Allied Products (2800) | 132578432 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1530884 | A. William Backus | C/O Balchem Corporation 5 Paragon Drive Montvale NJ 07645 | Vp & Chief Accounting Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-23 | 5,480 | $84.40 | 18,394 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-23 | 3,700 | $74.57 | 22,094 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-23 | 6,703 | $156.16 | 15,391 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-23 | 2,477 | $156.94 | 12,914 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-26 | 2,581 | $154.36 | 10,333 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-26 | 4,319 | $155.66 | 6,014 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-26 | 100 | $156.13 | 5,914 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2024-02-23 | 5,480 | $0.00 | 5,480 | $85.40 |
| Common Stock | Stock Options (right to buy) | Disposition | 2024-02-23 | 3,700 | $0.00 | 3,700 | $74.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-02-21 | No | 4 | M | Direct | |
| 0 | 2028-02-15 | No | 4 | M | Direct |
Footnotes
- Exercise of fully vested non-qualified stock options.
- This transaction was executed in multiple sales ranging from $155.4950 to $156.4825 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- This transaction was executed in multiple sales ranging from $156.5300 to $157.1950 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- This transaction was executed in multiple sales ranging from $154.0800 to $155.0300 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- This transaction was executed in multiple sales ranging from $155.1300 to $156.0500 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- Stock options that vested 20% on February 21, 2018, 40% on February 21, 2019, and 40% on February 21, 2020, and are exercisable.
- Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable.
Billionaire Hedge Funds
